Sign in
4/A

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000950170-23-013483

Options or other derivatives

  • Chief Financial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Burrell Terry-Ann Chief Financial Officer 2023-01-31 Grant or award · Stock Option (Right to Buy) +40,000 40,000 D
Loading xslF345X04/ownership.xml…